Immunomedics Inc
(IMMU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,419 | 661 | -2,231 | N/A | -15,962 |
| Depreciation Amortization | -17,258 | -10,303 | -3,338 | N/A | 1,280 |
| Other Working Capital | 256 | -760 | -512 | N/A | 768 |
| Other Operating Activity | 41,235 | 40,689 | 40,068 | 0 | 4,464 |
| Operating Cash Flow | $25,652 | $30,287 | $33,988 | $N/A | $-9,450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -530 | -453 | -190 | N/A | -156 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -259,000 |
| Sale Of Investment | 700 | 600 | N/A | N/A | 257,145 |
| Investing Cash Flow | $170 | $147 | $-190 | $N/A | $-2,010 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -956 |
| Common Stock Issued | 7 | 7 | 7 | N/A | 84 |
| Financing Cash Flow | $7 | $7 | $7 | $N/A | $-872 |
| Beginning Cash Position | 6,133 | 6,133 | 6,133 | N/A | 19,088 |
| End Cash Position | 31,962 | 36,573 | 39,937 | N/A | 6,755 |
| Net Cash Flow | $25,830 | $30,441 | $33,805 | $N/A | $-12,333 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,652 | 30,287 | 33,988 | N/A | -9,450 |
| Capital Expenditure | -530 | -453 | -190 | N/A | -156 |
| Free Cash Flow | 25,123 | 29,834 | 33,797 | 0 | -9,606 |